Akums Drugs slips 3% after posting 66% decline in Q3 profits, rev down 7%

Quick Summary:

Akums Drugs reported a decline of 66 per cent year-on-year (Y-o-Y) to Rs 65.18 crore as compared to Rs 193.

The company is well-known for its contract manufacturing services, providing products for both global and Indian pharmaceutical companies.

The company to be incorporated are Akums Healthcare UK and Akums Healthcare Malta Ltd.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaMaltaUnited Kingdom

Topics: Nifty Sensex Akums drugs share Bse Buzzing stocks Nse Akums share price Markets Market today Akums shae pricem akums drugs share price

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-02-07 @ 13:18:58 (5 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 440 words

Reading Time: 3 minutes read

Sentences: 22 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 25957063

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 304 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions